Indresh K. Srivastava

4.1k total citations
75 papers, 3.1k citations indexed

About

Indresh K. Srivastava is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Indresh K. Srivastava has authored 75 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Virology, 40 papers in Immunology and 30 papers in Infectious Diseases. Recurrent topics in Indresh K. Srivastava's work include HIV Research and Treatment (53 papers), Immune Cell Function and Interaction (28 papers) and HIV/AIDS drug development and treatment (16 papers). Indresh K. Srivastava is often cited by papers focused on HIV Research and Treatment (53 papers), Immune Cell Function and Interaction (28 papers) and HIV/AIDS drug development and treatment (16 papers). Indresh K. Srivastava collaborates with scholars based in United States, France and United Kingdom. Indresh K. Srivastava's co-authors include Akhil B. Vaidya, Susan W. Barnett, Hagai Rottenberg, Jeffrey B. Ulmer, Leonidas Stamatatos, Elaine Kan, John Donnelly, Manmohan Singh, David C. Montefiori and Margaret A. Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Indresh K. Srivastava

75 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Indresh K. Srivastava United States	31	1.3k	1.2k	983	789	752	75	3.1k
D. Noah Sather United States	27	1.3k 1.0×	1.1k 0.9×	768 0.8×	365 0.5×	557 0.7×	70	2.4k
Peter Hobart United States	31	753 0.6×	1.5k 1.2×	2.6k 2.6×	712 0.9×	951 1.3×	54	4.8k
Walter R. Weiss United States	28	528 0.4×	1.9k 1.5×	1.2k 1.2×	561 0.7×	468 0.6×	52	3.7k
Urszula Krzych United States	35	590 0.5×	1.9k 1.6×	1.4k 1.5×	626 0.8×	393 0.5×	78	4.3k
Ralf Altmeyer France	31	420 0.3×	749 0.6×	934 1.0×	778 1.0×	2.0k 2.6×	58	3.8k
Lbachir BenMohamed United States	44	530 0.4×	2.6k 2.1×	1.4k 1.5×	2.4k 3.0×	380 0.5×	134	4.7k
Yupin Charoenvit United States	35	606 0.5×	1.9k 1.5×	1.9k 1.9×	698 0.9×	496 0.7×	65	4.5k
Martin L. Bryant United States	28	1.0k 0.8×	596 0.5×	1.0k 1.1×	1.3k 1.6×	1.0k 1.3×	48	3.2k
Martha Sedegah United States	35	743 0.6×	2.4k 2.0×	2.1k 2.1×	826 1.0×	709 0.9×	106	5.2k
W. Ripley Ballou United States	31	588 0.5×	1.3k 1.0×	1.5k 1.5×	564 0.7×	476 0.6×	59	4.1k

Countries citing papers authored by Indresh K. Srivastava

Since Specialization

Citations

This map shows the geographic impact of Indresh K. Srivastava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Indresh K. Srivastava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Indresh K. Srivastava more than expected).

Fields of papers citing papers by Indresh K. Srivastava

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Indresh K. Srivastava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Indresh K. Srivastava. The network helps show where Indresh K. Srivastava may publish in the future.

Co-authorship network of co-authors of Indresh K. Srivastava

This figure shows the co-authorship network connecting the top 25 collaborators of Indresh K. Srivastava. A scholar is included among the top collaborators of Indresh K. Srivastava based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Indresh K. Srivastava. Indresh K. Srivastava is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kuck, Laura R., et al.. (2014). Titer on Chip: New Analytical Tool for Influenza Vaccine Potency Determination. PLoS ONE. 9(10). e109616–e109616. 20 indexed citations

Hickey, John M., Kathleen M. Holtz, Prakash Manikwar, et al.. (2014). Mechanism of a Decrease in Potency for the Recombinant Influenza A Virus Hemagglutinin H3 Antigen During Storage. Journal of Pharmaceutical Sciences. 103(3). 821–827. 14 indexed citations

Zeng, Yuhong, Lisa A. Kueltzo, Richard Schwartz, et al.. (2013). Development of a Stable Virus-Like Particle Vaccine Formulation against Chikungunya Virus and Investigation of the Effects of Polyanions. Journal of Pharmaceutical Sciences. 102(12). 4305–4314. 19 indexed citations

Dey, Antu, Brian Burke, Yide Sun, et al.. (2012). Elicitation of Neutralizing Antibodies Directed against CD4-Induced Epitope(s) Using a CD4 Mimetic Cross-Linked to a HIV-1 Envelope Glycoprotein. PLoS ONE. 7(1). e30233–e30233. 12 indexed citations

Dey, Antu, Brian Burke, Yide Sun, et al.. (2012). Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. Vaccine. 30(17). 2749–2759. 21 indexed citations

Malherbe, Delphine C., Nicole A. Doria‐Rose, Lynda Misher, et al.. (2011). Sequential Immunization with a Subtype B HIV-1 Envelope Quasispecies Partially Mimics the In Vivo Development of Neutralizing Antibodies. Journal of Virology. 85(11). 5262–5274. 68 indexed citations

Martin, Grégoire, Brian Burke, Robert Thaï, et al.. (2011). Stabilization of HIV-1 envelope in the CD4-bound conformation through specific cross-linking of a CD4 mimetic.. Journal of Biological Chemistry. 286(33). 29442–29442. 1 indexed citations

Dey, Antu & Indresh K. Srivastava. (2010). Novel adjuvants and delivery systems for enhancing immune responses induced by immunogens. Expert Review of Vaccines. 10(2). 227–251. 46 indexed citations

Derby, Nina, Sean A. Gray, Elizabeth A. Wayner, et al.. (2007). Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogens. Virology. 366(2). 433–445. 23 indexed citations

10.

Duong, Yen T., D. Christopher Meadows, Indresh K. Srivastava, Jacquelyn Gervay‐Hague, & Thomas W. North. (2007). Direct Inactivation of Human Immunodeficiency Virus Type 1 by a Novel Small-Molecule Entry Inhibitor, DCM205. Antimicrobial Agents and Chemotherapy. 51(5). 1780–1786. 5 indexed citations

11.

Xu, Rong, Indresh K. Srivastava, Catherine E. Greer, et al.. (2006). Characterization of Immune Responses Elicited in Macaques Immunized Sequentially with Chimeric VEE/SIN Alphavirus Replicon Particles Expressing SIVGag and/or HIVEnv and with Recombinant HIVgp140Env Protein. AIDS Research and Human Retroviruses. 22(10). 1022–1030. 28 indexed citations

12.

Xu, Rong, Indresh K. Srivastava, LaRene Kuller, et al.. (2006). Immunization with HIV-1 SF162-derived Envelope gp140 proteins does not protect macaques from heterologous simian-human immunodeficiency virus SHIV89.6P infection. Virology. 349(2). 276–289. 30 indexed citations

13.

Burke, Brian, Nina Derby, Zane Kraft, et al.. (2006). Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Virology. 355(2). 138–151. 13 indexed citations

14.

Peng, Bo, Raúl Gómez Román, David C. Montefiori, et al.. (2005). Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies. Journal of Virology. 79(16). 10200–10209. 85 indexed citations

15.

Srivastava, Indresh K., Jeffrey B. Ulmer, & Susan W. Barnett. (2005). Role of Neutralizing Antibodies in Protective Immunity Against HIV. Human Vaccines. 1(2). 45–60. 35 indexed citations

16.

Vajdy, Michael, Manmohan Singh, Jina Kazzaz, et al.. (2004). Mucosal and Systemic Anti-HIV Responses in Rhesus Macaques following Combinations of Intranasal and Parenteral Immunizations. AIDS Research and Human Retroviruses. 20(11). 1269–1281. 51 indexed citations

17.

Singh, Manmohan & Indresh K. Srivastava. (2003). Advances in Vaccine Adjuvants For Infectious Diseases. Current HIV Research. 1(3). 309–320. 31 indexed citations

18.

Srivastava, Indresh K. & Akhil B. Vaidya. (1999). A Mechanism for the Synergistic Antimalarial Action of Atovaquone and Proguanil. Antimicrobial Agents and Chemotherapy. 43(6). 1334–1339. 185 indexed citations

19.

Srivastava, Indresh K., Hagai Rottenberg, & Akhil B. Vaidya. (1997). Atovaquone, a Broad Spectrum Antiparasitic Drug, Collapses Mitochondrial Membrane Potential in a Malarial Parasite. Journal of Biological Chemistry. 272(7). 3961–3966. 324 indexed citations

20.

Srivastava, Indresh K., Béla Takács, Patrick Caspers, et al.. (1989). Recombinant polypeptides for serology of malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene. 83(3). 317–321. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact